218 related articles for article (PubMed ID: 6948760)
1. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukaemia in Norway. Report on a national treatment program.
Moe PJ; Seip M; Finne PH
Haematologia (Budap); 1981; 14(3):257-63. PubMed ID: 6948760
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
3. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program.
Moe PJ; Seip M; Finne PH
Acta Paediatr Scand; 1981 Jan; 70(1):73-9. PubMed ID: 6971042
[No Abstract] [Full Text] [Related]
4. High-dose methotrexate in acute lymphocytic leukemia.
Freeman AI; Wang JJ; Sinks LF
Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia.
Evans WE; Abromowitch M; Crom WR; Relling MV; Bowman WP; Pui CH; Ochs J; Dodge R
NCI Monogr; 1987; (5):81-5. PubMed ID: 3481040
[TBL] [Abstract][Full Text] [Related]
6. Complications of intrathecal methotrexate prophylaxis and treatment of central nervous system leukemia in children.
Kobayashi Y; Ishigame Y; Hara M; Nitta Y; Higaki T
Hiroshima J Med Sci; 1976 Sep; 25(2-3):107-13. PubMed ID: 1071901
[No Abstract] [Full Text] [Related]
7. [Diagnosis and therapy of central nervous system complications of acute leukemia in childhood].
Masera G; Carnelli V
Haematol Lat; 1969; 12(3):831-5. PubMed ID: 5273189
[No Abstract] [Full Text] [Related]
8. The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia. A comparison of three versus six courses.
Green DM; Brecher ML; Blumenson LE; Grossi M; Freeman AI
Cancer; 1982 Dec; 50(12):2722-7. PubMed ID: 6958351
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system and testicular involvement in acute lymphoblastic leukaemia.
Saikia TK; Gopal R; Nair CN; Nadkarni KS; Dinshaw KA; Kamat DM; Rao DN; Advani SH
J Assoc Physicians India; 1985 Jul; 33(7):457-9. PubMed ID: 3863812
[No Abstract] [Full Text] [Related]
10. [Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)].
Fontana G; Rizzo SC; Ascari E; Ricevuti G; Balduini C; Santagati G
Haematologica; 1975 Jun; 60(2):207-29. PubMed ID: 808453
[No Abstract] [Full Text] [Related]
11. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse.
Brecher ML; Weinberg V; Boyett JM; Sinks LF; Jones B; Glicksman A; Holland JF; Freeman AI
Cancer; 1986 Sep; 58(5):1024-8. PubMed ID: 3524797
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate.
Wang JJ; Freeman AI; Sinks LF
Cancer Res; 1976 Apr; 36(4):1441-4. PubMed ID: 1063065
[TBL] [Abstract][Full Text] [Related]
13. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia (ALL).
Freeman AI; Brecher ML; Wang JJ; Sinks LF
Haematol Blood Transfus; 1979; 23():115-23. PubMed ID: 296106
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
de Vaan GA; Marcar JR; Schretlen ED
Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
[No Abstract] [Full Text] [Related]
15. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
[TBL] [Abstract][Full Text] [Related]
16. [Central nervous system infiltration in acute leukemias in children].
Kozlowska J; Rokicka-Milewska R
Pediatr Pol; 1967 Aug; 42(8):919-25. PubMed ID: 5233716
[No Abstract] [Full Text] [Related]
17. [Intracerebral calcifications associated with intrathecal methotrexate therapy in acute lymphocytic leukemia (author's transl)].
Jürgenssen OA
Padiatr Padol; 1979; 14(1):111-6. PubMed ID: 283372
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate infusions in poor prognosis acute lymphoblastic leukemia in children: I. The Norwegian methotrexate study in acute lymphoblastic leukemia in childhood, August 1975-December 1980.
Moe PJ; Seip M; Finne PH; Kolmannskog S
Med Pediatr Oncol; 1986; 14(3):187-8. PubMed ID: 3462465
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate in childhood all.
Moe PJ; Holen A
Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
